euroPLX 55 2014

euroPLX Partnering Conferences are the place for pharma deals since almost 20 years. They are attended by business development decision makers, CEOs, owners of medium-sized drug producers, vice presidents, directors, managers with decision power, and some trainees. Brokers or consultants are admitted provided that they have clear mandates. euroPLX delivers an average of more than 23 pre-scheduled appointments per participating company.
Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this conference. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution. It will be displayed on this page as soon as a sufficient number of collaboration interests are submitted